Medical/Pharmaceuticals
Panoramic Atlases of Life Published in Cell Mark Establishment of SpatioTemporal Omics Consortium
STOC launches with more than 80 scientists joining globally, focused on obtaining the greatest scientific benefits fromspatially resolved transcriptomics technology; first studies use BGI-Research's Stereo-seq to produce spatiotemporal cellular maps of mice, Drosophila, zebrafish, and Arabidopsi...
2022-05-05 09:00
3401
Panoramic Atlases of Life Published in Cell Mark Establishment of SpatioTemporal Omics Consortium
STOC launches with more than 80 scientists joining globally, focused on obtaining the greatest scientific benefits fromspatially resolved transcriptomics technology; first studies use BGI-Research's Stereo-seq to produce spatiotemporal cellular maps of mice, Drosophila, zebrafish, and Arabidopsi...
2022-05-05 09:00
1931
First Patient Dosed in Phase II Renal Cancer Theranostics Study
MELBOURNE, Australia and INDIANAPOLIS, May 5, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that a first patient has been dosed in the 'STARLITE 2' Phase II study of the Company's investigational renal cancer therapy, TLX250 (177 Lu-DOTA-girentu...
2022-05-05 05:00
2206
Nanoform launches "STARMAP® Online" placing AI-power at the fingertips of medicine developers
HELSINKI, May 4, 2022 /PRNewswire/ -- Nanoform Finland Plc., an innovative nanoparticle medicine-enabling company, today announced that it has launched its sparse-data AI solution (STARMAP® Online) as a secure online portal for direct use by its current and future partners. Since its inception i...
2022-05-04 14:35
1834
Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets*
LUGANO, Switzerland, and SINGAPORE, May 4, 2022 /PRNewswire/ -- Juniper Biologics Pte Ltd, a science-led healthcare company focused on researching, developing and commercializing novel therapies, and Helsinn Group, a fully integrated, global biopharma company with a diversified pipeline of innova...
2022-05-04 14:00
2064
China Mobile Hong Kong Launches Online Medical App "Dr. HK"
Four Major Features Providing Doctor Consultation and Prescription While Staying at Home Medicine Doorstep Delivery in 4 hours at the earliest Free of Charge Video Consultation, Medication and Delivery for First 500 Users HONG KONG, May 4, 2022 /PRNewswire/ -- With the rise of the digital lifest...
2022-05-04 12:00
4106
European Stroke Organisation Conference 2022: New study links gut microbiota strains with more severe strokes and poorer post-stroke recovery
LYON, France, May 4, 2022 /PRNewswire/-- A new study has identified strains of gut microbiota that are associated with more severe strokes and worse post-stroke recovery, revealing that the gut microbiome could be an important factor in stroke risk and outcomes. The study, presented today at the...
2022-05-04 06:00
2845
3M Littmann CORE Digital Stethoscope Honored in Fast Company's 2022 World Changing Ideas Awards
ST. PAUL, Minn., May 4, 2022 /PRNewswire/ -- 3M™ Littmann® today announced its 3M™ Littmann® CORE Digital Stethoscope received honorable mention accolades in thehealth category of the 2022 Fast Company World Changing Ideas global awards program recognizing companies, products and initiatives that...
2022-05-04 04:50
2855
Sun Nuclear Introduces SunSCAN™ 3D, Next-Generation Cylindrical Water Scanning System
System to Debut at ESTRO Annual Congress & Upcoming Online Release Event MELBOURNE, Fla., May 3, 2022 /PRNewswire/ -- Sun Nuclear Corporation (Sun Nuclear), a wholly-owned subsidiary of Mirion Technologies, Inc. (NYSE: MIR) ("Mirion"), today announced the release of theSunSCAN™ 3D cylindrical wa...
2022-05-03 20:03
2550
Biomerics Announces Image Guided Intervention (IGI) Division
SALT LAKE CITY, May 2, 2022 /PRNewswire/ -- Biomerics, a leading vertically integrated contract manufacturer for the attractive interventional device market, announced the creation of a new division, Biomerics Image Guided Intervention (IGI). Biomerics' IGI Division, headquartered inSalt Lake Cit...
2022-05-02 22:18
2077
CIVCO Radiotherapy to Unveil TotalRT All in One Solution at ESTRO 2022
CORALVILLE, Iowa, May 2, 2022 /PRNewswire/ -- CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, will unveil the TotalRT All in One Solution along with several innovative solutions during the annual ESTRO Congress inCopenhagen, De...
2022-05-02 14:00
2335
ASCENSIA DIABETES CARE PRESENTS NEW RESEARCH SHOWING THAT PEOPLE USING THE CONTOUR® BLOOD GLUCOSE MONITORING SYSTEM AND APP EXPERIENCE FEWER OUT-OF-TARGET BLOOD GLUCOSE LEVELS
BASEL, Switzerland, May 2, 2022 /PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, maker of CONTOUR® blood glucose monitoring (BGM) system portfolio and distributor of the Eversense® continuous glucose monitoring (CGM) system, announces a new study demonstrating that people w...
2022-05-02 13:00
2714
Asia Pacific Initiative on Reproduction (ASPIRE) 2022 Congress: Frozen embryos, sperm and eggs will be big travellers in post COVID-19 cross border reproductive care
SINGAPORE, May 2, 2022 /PRNewswire/ -- The aftermath of the COVID-19 pandemic is expected to have major impacts on the nature of cross border reproductive care where infertile couples and individuals in the past travelled extensively abroad to access medically assisted conception. The 2022 Con...
2022-05-02 11:46
7449
Servatus strengthens Board with appointment of biopharmaceutical division head at Boehringer Ingelheim, Dr Uwe Buecheler
* New Board appointment deepens and consolidates Servatus' extensive commercial and scientific expertise for its global biotherapeutics programs * Dr Buecheler joins as Non-Executive Director from leading pharmaceutical giant Boehringer Ingelheim inGermany, where he is both Senior Vice Preside...
2022-05-02 07:36
3186
Asia Pacific Initiative on Reproduction (ASPIRE) 2022 Congress: Recognising the 'tip of the iceberg' in the complex and chronic effects of endometriosis
SINGAPORE, May 1, 2022 /PRNewswire/ -- Leaders in reproductive medicine from more than 100 countries were today urged to help prevent women suffering from the debilitating effects of endometriosis from embarking on "diagnostic misadventures." Speaking at the 2022 Congress of the Asia Pacific I...
2022-05-01 16:00
9686
Asia Pacific Initiative on Reproduction (ASPIRE) 2022 Congress: Linking male infertility diagnosis with the window to future health trajectories
SINGAPORE, May 1, 2022 /PRNewswire/ -- Male infertility factors are emerging as likely biomarkers for later life health events including hospital treatments and possible premature death from conditions such as cancer, cardiovascular and metabolic diseases. Lifestyle and social factors, includi...
2022-05-01 13:30
4859
Global Cord Blood Corporation Announces Entry into Cell Therapy Market by Acquiring Cellenkos and Its Products Rights
HONG KONG, April 30, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO, "GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, announced today that the Company will acquire 100% ...
2022-04-30 04:16
9252
Hikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticals
LONDON, April 30, 2022 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma) confirms that it has not entered into any transaction with Opiant Pharmaceuticals, contrary to a PR Newswire announcement issued today indicating that Opiant Pharmaceuticals and Hikma have entered into a commercialisation an...
2022-04-30 02:08
2639
Antengene Announces Latest Clinical Trial Data of ATG-008 (onatasertib) to be presented in the upcoming 2022 American Society of Clinical Oncology Annual Meeting
SHANGHAI and HONG KONG, April 29, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and onc...
2022-04-29 22:30
2830
Biocytogen Enters into Antibody Agreement with Merck
BEIJING, April 29, 2022 /PRNewswire/ -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen) announced that it has entered into an evaluation and option agreement with Merck to grant them a sole license to evaluate Biocytogen's proprietary antibodies against at least three distinct targets...
2022-04-29 20:00
2630
Week's Top Stories
Most Reposted
k-ID Closes $45 Million Series A from Andreessen Horowitz and Lightspeed Venture Partners to Set a New Global Benchmark for Age-appropriate Gaming Experiences
[Picked up by 320 media titles]
2024-06-25 21:00
10 Start-ups Awarded in HK Tech 300 Southeast Asia Start-up Competition Fostering Innovation & Entrepreneurship Beyond Boundaries
[Picked up by 317 media titles]
2024-06-27 18:56
Labuan IBFC Inc. and STEP Malaysia jointly host wealth management and estate planning event
[Picked up by 315 media titles]
2024-06-28 12:45
SCO strengthening youth development for better future
[Picked up by 297 media titles]
2024-06-24 10:52
Fibocom Drives the Rapid Growth in the Economics of IoT Scale with Ultra-compact size Cat 1 bis Module MC610-GL at MWC Shanghai 2024
[Picked up by 286 media titles]
2024-06-26 10:00
Most Read
k-ID Closes $45 Million Series A from Andreessen Horowitz and Lightspeed Venture Partners to Set a New Global Benchmark for Age-appropriate Gaming Experiences
2024-06-25 21:00
12815
Lilyannie Christie Linus Crowned Miss Grand Malaysia Sabah 2024
2024-06-25 13:38
12436
SCO strengthening youth development for better future
2024-06-24 10:52
7191